These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14599963)

  • 1. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
    Li YJ; Meng YX; Ji XR
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
    Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
    Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
    Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
    Joo YE; Rew JS; Park CS; Kim SJ
    Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.
    Gunji N; Oda T; Todoroki T; Kanazawa N; Kawamoto T; Yuzawa K; Scarpa A; Fukao K
    Cancer; 1998 May; 82(9):1649-56. PubMed ID: 9576284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
    Zou W; Hu CH; Zhou JP
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
    Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
    J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer.
    Li YJ; Ji XR
    World J Gastroenterol; 2003 Feb; 9(2):368-72. PubMed ID: 12532469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN; Li M
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
    Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
    Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
    Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
    Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
    Yang JF; Chen SL; Liu ZH; Zhang Y
    Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.